Outcome of NPM1 Mutated Acute Myeloid Leukemia (AML) Treated with Hypomethylating Agents (HMAs): A Report on 71 Cases

Pedro Henrique Prata; Cécile Bally; Thomas Prébet; Christian Récher; Geoffroy Venton; Xavier Thomas; Emmanuel Raffoux; Arnaud Pigneux; Thomas Cluzeau; Judith Desoutter

doi:10.1182/blood.v130.suppl_1.1335.1335

Outcome of NPM1 Mutated Acute Myeloid Leukemia (AML) Treated with Hypomethylating Agents (HMAs): A Report on 71 Cases

Identifier:nobleid.org/w1/20260515/DFB22ADC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFB22ADC.svg?ark=w1%2F20260515%2FDFB22ADC)](https://nobleid.org/work/w1/20260515/DFB22ADC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Outcome of NPM1 Mutated Acute Myeloid Leukemia (AML) Treated with Hypomethylating Agents (HMAs): A Report on 71 Cases

Identifier:nobleid.org/w1/20260515/DFB22ADC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFB22ADC.svg?ark=w1%2F20260515%2FDFB22ADC)](https://nobleid.org/work/w1/20260515/DFB22ADC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work